Disease Activity Score in 28 Joints Using GGT Permits a Dual Evaluation of Joint Activity and Cardiovascular Risk.
Hélène VergneaultEloïse VandebeuqueVeronica CodulloYannick AllanoreJerome AvouacPublished in: The Journal of rheumatology (2020)
GGT may be considered as a marker of systemic inflammation and CV risk in patients with RA. Based on these findings, we herein propose an original index, the DAS28-GGT, which is able to evaluate both joint disease activity and CV risk. This index will deserve further validation in prospective cohorts.